Multi-university study shows app can help students reduce symptoms, ease depression
College students access eating disorders therapy via phone app
Category: Research
African American children with autism experience long delays in diagnosis
Such delays lead to serious disparities in access to developmental therapy
Nasal Spray Is A New Antidepressant Option For People At High Risk of Suicide
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
$13.7 million to further adolescent brain development study
Grant from National Institute on Drug Abuse to extend landmark study
Potential biomarker for autism identified in infants
Low levels of neuropeptide in babies’ cerebrospinal fluid linked to later diagnosis.
WashU to test OCD drug for potential COVID-19 treatment
Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
Can a long-used antidepressant stop COVID-19’s deadly ‘cytokine storm’?
Eric Lenze, MD, and Caline Mattar, MD, have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.
Suicidal thoughts in 9- and 10-year-olds correlate to family dynamics, study found
Research from Washington University in St. Louis is narrowing the gap in psychology’s understanding of suicidal thoughts in young people. The findings show that such thoughts begin as early as 9 and 10 years old.
$29 million for new phase of international Alzheimer’s study
Research focuses on precisely how the disease develops in the brain
Nature vs. nurture: Studying adversity’s effects on children’s brains
Compelled by the potential to improve the lives of vulnerable children, emeritus trustee Walter Metcalfe and his wife, Cynthia, have committed nearly $4 million through outright and estate gifts to support the work of Joan L. Luby, MD, a highly regarded child psychiatrist.